Accrued Expenses and Other Current Liabilities

6 Months Ended

Jun. 30, 2018

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

(in thousands)	JUNE 30, 2018		DECEMBER 31, 2017
Accrued compensation and benefits	$	6,890	$	7,886
Accrued consulting and professional fees	3,601		3,841
Accrued research and development expenses (1)	1,742		1,855
Accrued other (2)	7,783		5,357
Total accrued expenses and other current liabilities	$	20,016	$	18,939

(1) Comprised of accruals related to fees for investigative sites, contract research organizations, contract manufacturing organizations and other service providers that assist in conducting preclinical research studies and clinical trials.

(2) Comprised of accruals related to commercial manufacturing activities prior to FDA approval of Rhopressa^®, interest payable and other business-related expenses.